Capital Conversations: COVID-19 and FDA; Medical, Legal, and Regulatory Perspectives

Capital Conversations: COVID-19 and FDA; Medical, Legal, and Regulatory Perspectives

From: Teleforum
0 0 about 1 month ago
During the COVID-19 pandemic, the United States Food and Drug Administration (FDA) has sought to exercise regulatory flexibilities where possible to expedite the development of timely medical products and ensure the safety of consumers. As the pandemic has evolved and new scientific evidence has emerged, the FDA has needed to adapt its policies and develop new programs to support the public health response. In this teleforum, senior agency officials will share their perspectives on the key ... See More

Find us on Facebook

iAB member
Copyright 2020 - Spreaker Inc. a Voxnest Company - Create a podcast - New York, NY
Help